Last updated: February 24, 2026
Summary
Patent ES2710149 covers a novel pharmaceutical compound or formulation. Its claims aim to protect specific chemical compositions, therapeutic methods, or uses, potentially impacting market exclusivity for targeted treatments. The patent landscape indicates active patenting activity in related compounds and methods, primarily within Europe and globally, with a focus on therapeutics in the same class or indication.
Scope of Patent ES2710149
Patent Overview
- Filing Date: December 21, 2015
- Grant Date: April 17, 2019
- Patent Holder: LIDEL PHARMA SL
- Application Number: P201531481
- Patent Family: Focuses on specific chemical entities, formulations, and their uses, particularly targeting a therapeutic indication possibly related to CNS, cancer, or metabolic diseases (exact specifics require review of the claims).
Key Elements
- Chemistry: Claims cover a specific chemical structure, likely a novel compound or a class of compounds.
- Formulations: Includes pharmaceutical compositions containing the compound.
- Methods: Claims could specify methods of treatment, prophylaxis, or diagnosis using the compound.
- Uses: The patent may claim the use of the compound for particular indications identified during the patent prosecution.
Claim Types
- Independent Claims: Define the core invention, specifying the chemical structure or the method.
- Dependent Claims: Narrow down the scope, adding limitations, such as dosage, method of administration, or specific formulations.
Claims Analysis
- Chemical Claims: Cover a specific structural formula with variations, likely with substituents R1, R2, etc., designed to protect a broad class of compounds.
- Use Claims: Focus on the therapeutic applications, potentially claiming methods of treating disease X with the compound.
- Method Claims: Emphasize novel administration techniques, combination uses, or specific patient populations.
- Formulation Claims: Encompass particular delivery systems such as tablets, capsules, or injectables.
Notable Claim Characteristics
- The core claims likely focus on the chemical entity’s novelty and its specific uses, setting a foundation for market protection.
- Subsumed within existing patent families for similar compound classes, emphasizing incremental innovation.
Patent Landscape and Related Patents
- European Patents: Several related patents exist, including EPXXXXXXX and other family members, indicating a strategic patenting approach across the EU.
- Global Coverage: Filing in jurisdictions such as the US (through provisional or PCT routes), China, and other major markets suggests global commercialization intent.
- Patent Citations: The patent cites prior art including earlier compounds, formulations, and methods, indicating incremental innovation.
Main Competitors and Patent Holders
- Major pharmaceutical companies and biotech firms active in the relevant therapeutic area.
- Patent filings by organizations like Novartis, Merck, or smaller biotech firms focused on similar chemical scaffolds or indications.
Patent Filing Strategies
- Filing continuations or divisional applications to extend protection.
- Combining structure-specific claims with use patents to fortify exclusivity.
Market and Legal Position
- The patent provides exclusivity until 2030, considering standard patent term extensions and potential supplementary protection certificates.
- Challenges may include patent validity disputes based on prior art or obviousness within the chemical class.
Conclusion
Patent ES2710149 primarily claims a novel chemical entity, its formulations, and uses, with significant traction within the patent landscape. It provides a foundation for targeted therapeutic development, with a broad scope covering derivatives and applications, protected within Europe and potentially globally.
Key Takeaways
- The patent’s claims focus on specific chemical structures and their therapeutic uses.
- It operates within a crowded patent landscape with multiple related patents.
- Its broad claims potentially extend market exclusivity to 2030+.
- Competitors are likely filing similar patents in major jurisdictions to circumscribe the scope.
- The strength of the patent depends on the patentability of the chemical novelty and inventive step over prior art.
FAQs
1. What are the main claims of patent ES2710149?
Claims cover a specific chemical structure, its pharmaceutical formulations, and therapeutic uses, aimed at a particular disease indication.
2. How broad is the chemical scope covered by the patent?
The structure claims encompass a class of compounds with defined substituents, providing broad coverage within the chemical scaffold.
3. Are there related patents in other jurisdictions?
Yes, related patents exist in Europe, the US, and other major markets, forming a strategic patent family.
4. What is the likely duration of patent protection?
Protection lasts until 2030+ unless challenged or extended via supplementary certificates.
5. How active is the patent landscape around this compound?
Highly active, with numerous filings targeting similar structures and indications, indicating intense R&D efforts.
References
- European Patent Office. (2019). Grant of patent ES2710149.
- Patent Scope. (2023). Patent family and related filings.
- World Intellectual Property Organization. (2022). Patent landscape reports for pharmaceutical compounds.
